Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Go back to Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights| (NASDAQ: CADL) | Delayed: 9.34 +0.07 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.27 | 52 Week High | $ | |||
| Open | $9.24 | 52 Week Low | $ | |||
| Day High | $9.61 | P/E | N/A | |||
| Day Low | $9.06 | EPS | $ | |||
| Volume | 735,898 | |||||

